Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Saba El-Gendi"'
Autor:
Heba R. Gouda, Iman M. Talaat, Amal Bouzid, Hoda El-Assi, Amira Nabil, Thenmozhi Venkatachalam, Poorna Manasa Bhamidimarri, Inken Wohlers, Amena Mahdami, Saba EL-Gendi, Ahmed ElKoraie, Hauke Busch, Maha Saber-Ayad, Rifat Hamoudi, Nahed Baddour
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Glomerulonephritis (GN) is a complex disease with intricate underlying pathogenic mechanisms. The possible role of underlying complement dysregulation is not fully elucidated in some GN subsets, especially in the setting of autoimmunity or infection.
Externí odkaz:
https://doaj.org/article/ab073b6271fc47a0a92f1aa18732fd6e
Publikováno v:
Medicine Updates.
Publikováno v:
ALEXMED ePosters. 4:27-28
Autor:
Saba El-Gendi, Sana Hosny Barakat, Marwa Ahmed Meheissen, Aml Mohamed Mahfouz, Ingy Ali Fouad
Publikováno v:
Journal of Tropical Pediatrics. 67
Background The severity of Helicobacter pylori infection is determined by the interplay between bacterial virulence, host genetic and environmental factors. This study aimed to identify interleukin-1 beta (IL-1β) and interleukin receptor antagonist
Publikováno v:
Egyptian Journal of Pathology. 37:48-55
Autor:
Saba El-Gendi, Ghada Abu-Sheasha
Publikováno v:
Pathology & Oncology Research. 24:309-322
Deregulation of the cell cycle regulating genes is common in urothelial bladder carcinoma (UBC). We aimed to examine the prognostic significance of ki-67, p53, p63 and cyclinD1expression in UBC and to identify optimal cut-off points to help identifyi
Publikováno v:
HPB. 23:S160
Autor:
Iman M. Talaat, Saba El-Gendi, Noha El-Sawy, Heba Sh. Kassem, Ghada A. Achmawi, Hoda H. El Assi
Publikováno v:
Egyptian Journal of Pathology. 36:61-65
Publikováno v:
Pediatrics. 146:591-591
Autor:
Mohamed Farouk Mostafa, Saba El-Gendi
Publikováno v:
Pathology & Oncology Research. 22:461-470
The Runx family of transcription factors has been implicated in cancer progression, both positively and negatively. Recent studies assigned a role for Runx2 in promoting breast cancer metastasis. However, the role of Runx2 during the early stage of b